Healthcare (SH:603313) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-08-01 23:18Group 1 - The company has approved a share repurchase plan, allowing for the repurchase of shares between RMB 85 million and RMB 170 million through centralized bidding, aimed at employee stock ownership plans or equity incentives [1] - The repurchase price will not exceed 150% of the average trading price of the company's shares over the 30 trading days prior to the board's decision [1] - The repurchase period is set for up to 12 months from the board's approval date [1] Group 2 - As of the end of July 2025, the company has repurchased a total of 18.79315 million shares, representing 3.29% of the total share capital, with a total expenditure of approximately RMB 161.19 million [2] - The highest purchase price recorded was RMB 9.139 per share, while the lowest was RMB 8.070 per share [2] - The progress of the repurchase aligns with the established share repurchase plan [3] Group 3 - The company will adhere to relevant regulations regarding share repurchase and will make decisions based on market conditions during the repurchase period [4] - The company commits to timely information disclosure regarding the progress of the share repurchase [4]